Craft

Episurf Medical

Stock Price

KR0.1

2024-10-29

Market Capitalization

KR91.7 M

2024-10-29

Revenue

KR13.5 M

FY, 2025

Episurf Medical Summary

Company Summary

Overview
Episurf Medical is a medical device company that develops, manufactures, and commercializes solutions for the repair of local cartilage damage in human joints. The Company's goal is to mainstream patient-specific treatment options within the orthopedic industry by means of the personalization of implants and instruments that are based on magnetic resonance imaging (MRI) and enable less invasive treatment. 
Type
Public
Status
Active
Founded
2009
HQ
Stockholm, SE | view all locations
Website
http://episurf.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Veronica Wallin

    Veronica Wallin, CFO

    • Fredrik Zetterberg

      Fredrik Zetterberg, Marketing Director

      • Pal Ryfors

        Pal Ryfors, CEO

        • Katarina Flodstrom

          Katarina Flodstrom, COO

          LocationsView all

          1 location detected

          • Stockholm, Stockholms län HQ

            Sweden

            60 Karlavägen

          Episurf Medical Financials

          Summary Financials

          Revenue (FY, 2025)
          kr13.5M
          Gross profit (FY, 2025)
          kr6.0M
          Net income (FY, 2025)
          (kr58.2M)
          Cash (FY, 2025)
          kr7.1M
          EBIT (FY, 2025)
          (kr57.8M)
          Enterprise value
          $89.5M

          Footer menu